Johnson & Johnson to boost U.S. investments to over $55B
Johnson & Johnson (NYSE:JNJ) on Friday announced plans to boost its U.S. investments to more than $55B over the next four ...
J&J (JNJ) Commits $55B to U.S. Manufacturing Expansion as Trump’s Tariffs Pressure Mounts
Johnson & Johnson (JNJ) announced its plans to invest over $55 billion over the next four years in the U.S. to strengthen its ...
Johnson & Johnson To Invest $55 Billion In US To Boost Manufacturing, Drug Discovery
Johnson & Johnson has announced a $55 billion investment in the U.S. over the next four years. This move will boost American ...
EconoTimes13h
Johnson & Johnson to Invest $55 Billion in U.S. Manufacturing and R&D Expansion
Johnson Johnson (NYSE: JNJ) announced plans to invest over $55 billion in the United States over the next four years, ...
Jim Cramer Says Johnson & Johnson (JNJ) Stock Could Fall to $160 Level
We recently published a list of Jim Cramer’s Latest Stock Moves: Top 10 Calls. In this article, we are going to take a look ...
PharmExec5h
Johnson & Johnson to Invest Over $55 Billion in US Manufacturing Facilities
The investment, which is a 25% increase from previous years, will support three new advanced manufacturing facilities, ...
Johnson & Johnson's Golden Cross: Technical Momentum Meets Groundbreaking Lung Cancer Breakthrough
JNJ stock hits Golden Cross, signaling potential long-term upside. Latest breakthrough in lung cancer treatment could provide additional catalyst.
Gov. Stein joins Johnson & Johnson groundbreaking for new Wilson facility
Johnson & Johnson will bring a surge in job opportunities and economic growth to the Wilson area. Paying more than twice the ...
FDA Approves Johnson & Johnson's Tremfya For Crohn's Disease
On Thursday, the U.S. Food and Drug Administration (FDA) approved Johnson & Johnson’s (NYSE JNJ) Tremfya (guselkumab), the ...